Phase II Clinical Trial to Evaluate a Vaccine Candidate for Gonorrhea

National Institute Of Allergy And Infectious Diseases

Investigators

Abstract

Support of a Phase II clinical trial to assess the efficacy of a vaccine to prevent gonococcal infection.